Skip to Content

Notice

Prospective Grant of Exclusive License: Biomedical Uses of Topoisomerase I Inhibitors Including Camptothecin and Derivatives for Retroviral Applications Including Human Immunodeficiency Virus (HIV)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.